Work

Pre-clinical studies and phase I clinical trial of the anti-CD22 immunotoxin CAT-3888 (BL22) for pediatric acute lymphoblastic leukemia (ALL)

Year: 2007

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2007.25.18_suppl.9560

Authors: A. Wayne, H. W. Findley, G. Lew, Y. Ahuja, L. Gu, M. Stetler-Stevenson, R. J. Kreitman, I. Pastan

Institutions: National Institutes of Health, Emory University, National Cancer Institute

Language: English

Topic: Toxin Mechanisms and Immunotoxins

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2268388996

Cites:

Cited by: 1

Related to: 10